A detailed history of Atria Wealth Solutions, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 3,846 shares of MEDP stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,846
Previous 6,403 39.93%
Holding current value
$1.19 Million
Previous $2.64 Million 51.38%
% of portfolio
0.01%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$320.58 - $457.29 $819,723 - $1.17 Million
-2,557 Reduced 39.93%
3,846 $1.28 Million
Q2 2024

Jul 22, 2024

BUY
$372.0 - $424.34 $405,108 - $462,106
1,089 Added 20.49%
6,403 $2.64 Million
Q1 2024

May 13, 2024

SELL
$284.87 - $413.31 $11,394 - $16,532
-40 Reduced 0.75%
5,314 $2.15 Million
Q4 2023

Feb 02, 2024

BUY
$227.52 - $312.68 $178,603 - $245,453
785 Added 17.18%
5,354 $1.64 Million
Q3 2023

Nov 08, 2023

BUY
$233.98 - $281.67 $112,310 - $135,201
480 Added 11.74%
4,569 $1.11 Million
Q2 2023

Aug 03, 2023

SELL
$187.26 - $240.17 $836,864 - $1.07 Million
-4,469 Reduced 52.22%
4,089 $982,000
Q1 2023

Aug 22, 2023

BUY
$174.31 - $239.52 $223,116 - $306,585
1,280 Added 31.3%
5,369 $1.01 Million
Q1 2023

Jun 14, 2023

BUY
$174.31 - $239.52 $555,874 - $763,829
3,189 Added 59.4%
8,558 $1.61 Million
Q1 2023

May 10, 2023

SELL
$174.31 - $239.52 $555,874 - $763,829
-3,189 Reduced 37.26%
5,369 $1.01 Million
Q4 2022

Aug 30, 2023

BUY
$153.06 - $226.57 $684,025 - $1.01 Million
4,469 Added 109.29%
8,558 $1.82 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $245,661 - $363,644
-1,605 Reduced 15.79%
8,558 $1.82 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $1.47 Million - $1.85 Million
10,163 New
10,163 $1.6 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.